BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8526120)

  • 1. Defects in the function of dendritic cells in murine retroviral infection.
    Gabrilovich DI; Patterson S; Harvey JJ; Woods GM; Elsley W; Knight SC
    Adv Exp Med Biol; 1995; 378():469-72. PubMed ID: 8526120
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of retrovirally induced immunosuppression acting via dendritic cells.
    Knight SC
    Adv Exp Med Biol; 1995; 378():423-7. PubMed ID: 8526109
    [No Abstract]   [Full Text] [Related]  

  • 3. Dendritic cells, apoptosis and murine retrovirus.
    Woods GM; Gabrilovich DI; Elsley W; English N; Knight SC
    Adv Exp Med Biol; 1995; 378():493-6. PubMed ID: 8526126
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of murine leukemia viruses on the function of dendritic cells.
    Gabrilovich DI; Roberts MS; Harvey JJ; Botcherby M; Bedford PA; Knight SC
    Eur J Immunol; 1993 Nov; 23(11):2932-8. PubMed ID: 8223870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrovirus-induced immunosuppression via blocking of dendritic cell migration and down-regulation of adhesion molecules.
    Gabrilovich DI; Woods GM; Patterson S; Harvey JJ; Knight SC
    Immunology; 1994 May; 82(1):82-7. PubMed ID: 8045596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine retrovirus induces defects in the function of dendritic cells at early stages of infection.
    Gabrilovich DI; Patterson S; Harvey JJ; Woods GM; Elsley W; Knight SC
    Cell Immunol; 1994 Oct; 158(1):167-81. PubMed ID: 8087863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-12 administration in retroviral infection of mice increases the potential to produce functional dendritic cells from bone marrow stem cells.
    Kelleher P; Williams NJ; Knight SC
    Immunol Lett; 1999 Jan; 65(1-2):51-4. PubMed ID: 10065627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism for dendritic cell dysfunction in retroviral infection of mice.
    Gabrilovich DI; Patterson S; Timofeev AV; Harvey JJ; Knight SC
    Clin Immunol Immunopathol; 1996 Aug; 80(2):139-46. PubMed ID: 8764558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine leukaemia virus infections as models for retroviral disease in humans.
    Roberts MS; Harvey JJ; Macatonia SE; Knight SC
    Adv Exp Med Biol; 1993; 329():533-7. PubMed ID: 8397476
    [No Abstract]   [Full Text] [Related]  

  • 10. A notable phenomenon recapitulated. A fusion product of a murine lymphoma cell and a leukemia virus-neutralizing antibody-producer host plasma cell formed spontaneously and secreting the specific antibody continuously.
    Sinkovics JG
    Acta Microbiol Immunol Hung; 2005; 52(1):1-40. PubMed ID: 15957233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation therapy using resistant donors for retrovirus-induced leukaemia in mice.
    Iwai H; Day NK; Hamada N; Inaba MM; Ikehara S; Good RA
    Clin Exp Immunol; 1994 Jan; 95(1):135-40. PubMed ID: 8287597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of fas/fasL in a murine retroviral infection by AZT and methionine enkephalin.
    Bowden R; Soto S; Specter S
    Adv Exp Med Biol; 2001; 493():143-52. PubMed ID: 11727760
    [No Abstract]   [Full Text] [Related]  

  • 13. Rauscher viral leukemogenesis in BALB/c mice treated with rabbit antimouse thymocyte serum.
    Siegel BV; Morton JI
    J Natl Cancer Inst; 1970 Mar; 44(3):573-9. PubMed ID: 11515425
    [No Abstract]   [Full Text] [Related]  

  • 14. Distribution of Fv-4 resistant gene product in Friend leukemia virus-resistant Fv-4r mouse strain.
    Kitagawa M; Aizawa S; Kamisaku H; Sado T; Ikeda H; Hirokawa K
    Exp Hematol; 1996 Oct; 24(12):1423-31. PubMed ID: 8913289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the immune response during the acute phase of E-55+ murine leukemia virus infection in progressor BALB and long term nonprogressor C57BL mice.
    Panoutsakopoulou V; Little CS; Sieck TG; Blankenhorn EP; Blank KJ
    J Immunol; 1998 Jul; 161(1):17-26. PubMed ID: 9647202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ecotropic murine leukemia viruses and exogenous mouse mammary tumor viruses are not essential for pristane-induced lupus.
    Akaogi J; Nacionales DC; Kuroda Y; Reeves WH; Satoh M
    Arthritis Rheum; 2003 Oct; 48(10):2990-2. PubMed ID: 14558108
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the susceptibility of C57BL-6 mice to Rauscher virus. 3. Kinetics of humoral antibody response to cell-surface antigens in neonatally inoculated mice.
    Ishimoto A; Ito Y
    J Natl Cancer Inst; 1973 Aug; 51(2):553-64. PubMed ID: 4765372
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of natural killer cells in resistance against friend retrovirus-induced leukemia.
    Iwanami N; Niwa A; Yasutomi Y; Tabata N; Miyazawa M
    J Virol; 2001 Apr; 75(7):3152-63. PubMed ID: 11238842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of non-H-2-linked genes on anti-virus immune responses and long-term survival in mice persistently infected with E-55+ murine leukemia virus.
    Avidan N; Tumas-Brundage KM; Sieck TG; Prystowsky MB; Blank KJ
    Virology; 1995 Aug; 211(2):507-15. PubMed ID: 7645254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of CD3 and CD5 donor T cell depletion on graft-versus-leukemia in a murine model for MHC-matched unrelated-donor transplantation.
    Okunewick JP; Kociban DL; Machen LL; Buffo MJ
    Bone Marrow Transplant; 1994 Jan; 13(1):11-7. PubMed ID: 7517254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.